Amaze Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.12 M
- Revenue Growth 154.88%
- Profit Growth 147.36%
- Ebitda 106.83%
- Net Worth 10.36%
- Total Assets 18.66%
About Amaze Pharmaceuticals
Amaze Pharmaceuticals Limited (APL) is a Public Limited Indian Non-Government Company incorporated in India on 21 October 2008 and has a history of 16 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹2.12 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233TG2008PLC061494
-
Company No.
061494
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
21 Oct 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Amaze Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vejju Rao
|
Director | 30-Sep-2020 | Current |
|
Mattaparti Devi
|
Director | 21-Oct-2008 | Current |
|
Alapati Purushottam
|
Director | 23-Aug-2013 | Current |
Financial Performance of Amaze Pharmaceuticals.
Amaze Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 154.88% increase. The company also saw a substantial improvement in profitability, with a 147.36% increase in profit. The company's net worth Soared by an impressive increase of 10.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amaze Pharmaceuticals?
In 2020, Amaze Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Serin Formulations Private LimitedVejju Rao is a mutual person
Charges (Loans)
₹0
₹2.12 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Aug 2015 | State Bank Of India | ₹0.92 M | Satisfied |
| 20 Sep 2014 | State Bank Of India | ₹1.20 M | Satisfied |
How Many Employees Work at Amaze Pharmaceuticals?
Unlock and access historical data on people associated with Amaze Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amaze Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amaze Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
